Cell regeneration and repair therapy

Cell regeneration and repair therapy is a medical method that can treat central nervous system cell damage, organ damage and immune system diseases. It has a good therapeutic effect on common diseases that extremely affect patients' health, such as cerebral palsy in children, Parkinson's disease, Alzheimer's disease, cirrhosis, myocardial infarction, rheumatoid arthritis, diabetes, etc. Below we will introduce to you the relevant knowledge of cell regeneration and repair therapy in detail!

1. Scope of application

(I) Central nervous system cell damage: cerebral palsy in children, cerebral atrophy, sequelae of stroke (cerebral infarction, cerebral hemorrhage), ataxia, Parkinson's disease, Alzheimer's disease, spinal cord injury (paraplegia) and other central nervous system damage diseases.

(ii) Organ damage: liver cirrhosis, pulmonary fibrosis, myocardial infarction, diabetes and diabetic complications, etc.

(iii) Immune system diseases: rheumatoid arthritis, lupus erythematosus, Crohn's disease, etc.

2. Principle

The core of targeted cell regenerative therapy is to extract specific "pluripotent cells" in the human body, utilize their biological activity, and after the necessary extraction, purification and culture processes, input them into the lesion site to change the local microenvironment of the lesion. Through the autocrine and paracrine pathways of cytokines, the body's self-repair ability is stimulated to the maximum extent, completing the in situ repair of damaged cells, restoring the functions of damaged tissues and organs, and achieving the purpose of treating diseases at the cellular level.

Studies have shown that this therapy is suitable for various cell-damaging diseases, including nerve damage such as cerebral palsy, spinal cord injury, brain atrophy, and sequelae of stroke; organ damage, including cirrhosis, pulmonary fibrosis, etc.; it can also be used to treat immune system diseases such as lupus erythematosus and rheumatoid arthritis.

3. Features

Targeted cell regenerative therapy has the characteristics of targeting, high efficiency, micronization and automation.

Targeting: Damaged and diseased tissues in the body will continue to release certain specific cytokines, called chemokines. The concentration of chemokines is lower in areas farther away from the damaged tissue, forming a concentration gradient with the high concentration in the adjacent damaged tissue. Under the guidance of the concentration gradient, the pluripotent cells injected into the patient's body can gradually move closer to and gather in the lesion area, forming a relatively high-concentration pluripotent cell population around the lesion tissue, which can fully play a role in tissue repair in the local lesion.

Efficiency: Experiments have shown that compared with the normal repair process of the human body, the speed of tissue repair after the introduction of pluripotent cells is dozens or even hundreds of times faster, allowing the damaged tissues of the human body to recover quickly in a short period of time.

Micro-targeted cell regenerative therapy occurs at the molecular level, producing a therapeutic effect on the diseased area on a cellular basis. The entire treatment process only requires infusion and injection. It is non-invasive and painless, and there is no need to bear the burden and risk of surgery.

Automation: After the introduction of pluripotent cells, all treatment processes will be completed step by step under the body's own regulation. If the patient needs it, he only needs to go to the hospital for treatment on time as required by the doctor, without the need for hospitalization. This provides convenience for patients who are busy with work, do not have much free time, and cannot be hospitalized.